JPRN-UMIN000028678
Recruiting
未知
Translational Research of Phase II study of FOLFIRI+Ramucirumab with early recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin / fluoropyrimidine (RAINCLOUD) - RAINCLOUD-TR
MCSGO: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group0 sites40 target enrollmentAugust 15, 2017
ConditionsColorectal Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Colorectal Cancer
- Sponsor
- MCSGO: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who are regarded as inadequate for study enrollment by investigators 2\) Patients who refuse to supply the samples
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Comparison of chemotherapy with radiochemotherapy as treatment of patients with locally advanced, primarily inoperable pancreatic carcinomalocally advanced, primarily inoperable pancreatic carcinomaTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001850-24-ATABCSG (Austrian Breast & Colorectal Cancer Study Group)112
Active, not recruiting
Phase 1
Evaluation of the efficacy of a combinaison treatment based upon immunotherapy + chemotherapy to treat patient with a stomach cancerAdvanced gastric or gastro-oesophageal junction adenocarcinomaMedDRA version: 20.0 Level: LLT Classification code 10042080 Term: Stomach cancer System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10026476 Term: Malignant neoplasm of stomach System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-002014-13-FRFédération Francophone de Cancérologie Digestive94
Active, not recruiting
Not Applicable
Phase II trial to evaluate the combination of FOLFOX6 + Bevacizumab in initially unresectable liver metastases from colorectal cancerMETASTHATIC COLON-RECTUM AND KIDNEY CANCERMedDRA version: 9.1Level: LLTClassification code 10055114Term: Colon cancer metastaticEUCTR2005-002269-35-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
Completed
Phase 2
A Multicenter, Clinical Phase II study of FOLFOXIRI with Bevacizumab As First-line Therapy in Patients with Metastatic Colorectal Cancer.Patients with metastatic colorectal cancer.JPRN-UMIN000013797EPS Corporation65
Active, not recruiting
Not Applicable
A randomized phase II study of FOLFORI plus or not CETUXIMAB in elderly advanced colorectal cancer patients.Elderly mestatic colorectal cancer patients, Wild-type KRAS ,70-80 years of age, ECOG 0-1.MedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000477-23-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI